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Abstract 
Study objective:  To investigate the hypothesis that biological ageing, as measured by age 
at diagnosis of some common cancers, is socio-economically patterned.  
Design:  A cross-sectional analysis of the association between an area based measure of 
material deprivation and age at diagnosis of four common cancers (breast, prostate, colorectal 
and lung cancers).  A further analysis, restricted to breast and colorectal cancer, allowed us to 
adjust for stage and grade of cancer at diagnosis. 
Setting:  The Northern and Yorkshire cancer registry and information service, Northern and 
Yorkshire region, UK. 
Participants:  All individuals living in the Northern and Yorkshire region diagnosed with 
breast, prostate, colorectal or lung cancer in 1986-1995.  All individuals living in the Northern 
and Yorkshire region diagnosed with breast or colorectal cancer in 1998-2000 with 
documented data on stage and grade of cancer at diagnosis. 
Main results:  There was evidence that greater material deprivation was associate with 
younger age at diagnosis of cancer in prostate (beta coefficient -0.073), colorectal (women:  
-0.042; men: -0.063) and lung cancer (women: -0.214; men: -0.161).  The opposite 
relationship was found in women with breast cancer (0.149).  Adjusting for stage and grade at 
incidence, where possible, had little effect on the magnitude of the beta coefficients. 
Conclusions:  Age at diagnosis of some common cancers appears to be socio-economically 
patterned with individuals from more deprived areas being diagnosed with prostate, colorectal 
and lung cancers earlier in life.  The opposite was seen in women with breast cancer.  In all 
cases the size of the effect was small.  Further work is required to investigate the socio-
economic distribution of more accurate measures of biological ageing. 
Keywords:  ageing, socio-economic position, cancer 
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Background 
Socio-economic differences in health (SEDH) have been widely documented and appear to be 
universal.[1-4]  However, the precise biological pathways linking socio-economic position 
(SEP) and health remain unclear.[5]  Although differential exposure to specific risk and 
protective factors is often cited as one of the key determinants of SEDH,[3] the relationship 
between SEP and specific risk and protective factors is not straightforward and appears to 
vary across both time and space.[6]  This challenges risk factor-specific explanations of 
SEDH – as soon as prevailing risk factors change, so too must associated explanations of 
SEDH. 
An alternative explanation of SEDH is that more fundamental pathways to health and disease 
exist and that specific risk and protective factors feed into these fundamental pathways.[7]  
Whilst the socio-economic distribution of specific risk and protective factors may vary over 
time, the socio-economic distribution of overall risk appears to be fairly constant in developed 
countries.  Sociologists have offered a number of explanations for why socio-economically 
deprived groups tend to experience the least healthy risk factor profiles in society.[8] 
One possible fundamental, biological mechanism of SEDH is biological ageing (Figure 1).[7]  
This is the progressive decrease in physiological ability to meet demands that occurs over 
time[9] and is currently understood to be due to the accumulation of damage at the cellular 
level.[10]  The rate of accumulation of cellular damage is determined by the balance between 
cellular damage occurring and the action of cellular defence and repair mechanisms.[10]  
Cellular damage includes mitochondrial damage, the accumulation of aberrant proteins within 
the cytosol, reactive oxygen species and the oxidative stress they generate and somatic 
mutations.[11]  Cellular defence and repair mechanisms include antioxidant vitamins and 
enzymes and DNA checking and repair enzymes. 
Unlike chronological ageing, there is considerable variation between individuals in the rate of 
biological ageing.[12]  Both genetic and environmental factors play a role[1314] and 
numerous environmental factors, known to be socio-economically patterned, are now known 
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to influence the rate of cellular damage accumulation, including cigarette smoking,[15] 
diet[16] and exposure to radiation.[17] 
Furthermore, there is good reason to believe that biological ageing and the accumulation of 
cellular damage are important determinants of health.  Population based research suggests that 
some crude markers of ageing, such as total and healthy life expectancy, are socio-
economically patterned.[1819]  However, no research, to date, has attempted to investigate 
the socio-economic distribution of more accurate measures of biological ageing.  Cancers are 
due, at the most proximate level, to acquired or inherited mutations in genes that control 
growth – specifically, oncogenes and tumour suppressor genes.[20]  As genetic mutations are 
one, well recognised, type of cellular damage,[11] the development of cancer can be 
understood as being closely related to the processes involved in biological ageing.  
Chronological age of development of cancer can, therefore, be used as a comparative measure 
of biological ageing.   
We investigated the effect of socio-economic position (SEP) on the age of development of 
some common cancers using data from a population based cancer registry. 
Methods 
The Northern and Yorkshire Cancer Registration and Information Service (NYCRIS) is one 
of nine regional cancer registries in England which aims to collect data on all incident cancers 
as they occur.  We used data held by NYCRIS to investigate the effects, if any, of SEP on age 
at diagnosis of cancer. 
Variables of interest 
Socio-economic position was measured using Townsend Deprivation Scores (TDS)[4] of the 
enumeration district of residence at date of diagnosis of cancer calculated from full seven 
digit postcode data and standardised to the NYCRIS region as a whole using data from the 
1991 census.  A positive TDS represents more material deprivation whilst a negative score 
represents less material deprivation. 
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Age at diagnosis of cancer was calculated from incident date and date of birth.  As is routine 
in UK cancer registries, incident date was defined as the first available (not necessarily 
earliest) date from: date of pathologically confirmed diagnosis, date of first hospital 
attendance during which a clinical diagnosis was made, date of diagnosis by a GP and date of 
death.   
Cancer site was assigned using three figure codes from the 10th revision of the International 
Classification of Diseases (ICD-10) as extrapolated from clinical records and recorded in the 
NYCRIS database.  We restricted the analysis to the four commonest non-skin cancer sites: 
breast (ICD-10 C50), colorectal (ICD-10 C18, C19 or C20), lung (ICD-10 C33 or C34) and 
prostate cancer (ICD-10 C61). 
Sample size and study years 
As no previous work in this area has been reported, we were unable to perform sample size or 
power calculations.  Instead, we adopted a pragmatic approach aiming to use as large a 
sample size as possible.  This was, however, restricted by our measure of SEP, TDS, which 
are calculated from decennial UK census data.  In order to avoid using data from more than 
one census, we restricted ourselves to 10 years of NYCRIS data and chose to centre our data 
collection years around a census year so that the maximum temporal extrapolation of census 
data would be five years.  The most recent census year for which data could be extrapolated 
five years both backwards and forwards was 1991.  We therefore chose 1986-1995 inclusive 
as our study years. 
Further analysis to assess the effects of adjusting for stage and grade at diagnosis 
Using the method described to determine incident date, and therefore age at diagnosis, does 
not necessarily result in comparable data for all individuals.  In order to minimise any bias or 
error introduced by this method, we wished to adjust for stage and grade of cancer at 
diagnosis.  However, these data were far from complete for the main study cohort and it was 
estimated that the only cohorts with more than 50% complete data on stage and grade were 
individuals registered with colorectal and breast cancers since 1998.  We, therefore, 
PRE-PUBLICATION MANUSCRIPT – NOT TO BE COPIED OR QUOTED 
WITHOUT PERMISSION 
  6 
performed a further analysis, using similar methods as the main study, which investigated the 
effect of adjusting for stage and grade at diagnosis on the relationship between age and TDS 
at diagnosis. This analysis used data on colorectal and breast cancers registered between 1998 
and 2000 inclusive. 
Exclusions 
Individuals were excluded from the analysis if:  key data were missing, registration had been 
by death certification only (and therefore the date of incidence had been recorded as the date 
of death),[21] or the incident cancer was a second primary.  Men with breast cancer were 
excluded due to the rarity of this condition. 
A proportion of individuals inherit a specific genetic defect which puts them at high risk of 
developing a cancer early in life.[22]  We felt that such individuals formed a distinct group 
and should not be included in the present analyses because of our focus on environmental 
factors.  As cancer registries do not routinely record information on inherited susceptibilities 
to cancer, we excluded the youngest 25% of individuals, at diagnosis, from each cancer and 
gender specific group as a conservative approach to removing all those whose cancer may 
include a substantial inherited component. 
Analysis 
Data was analysed in gender and cancer site specific groups throughout.  Linear regression 
techniques were used to assess the ability of TDS at diagnosis to predict age at diagnosis of 
cancer both before, and in the case of the 1998-2000 cohort, after adjustment for stage and 
grade of cancer at diagnosis.  Neither age nor TDS was normally distributed in any of the 
gender and cancer site specific groups.  As simple transformation did not result in appreciably 
more normal distributions of these variables, bootstrapping methods, with 1000 repetitions, 
were used to generate confidence intervals for beta coefficients derived from linear regression 
techniques.[23]  All analyses were performed in Intercooled Stata version 8.0. 
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Results 
The 1986-1995 cohort 
Between January 1st 1986 and December 31st 1995, 144 627 cases of lung, colorectal, prostate 
and breast cancer were registered with NYCRIS.  Of these, 39 301 (27.2%) met one of the 
exclusion criteria, including the age cut off, leaving 105 326 individuals in the analysis. 
Table 1 shows the distribution of age and TDS at diagnosis in the 1986-1995 cohort before 
and after exclusion of the youngest 25% of individuals at diagnosis.  In the cohort included in 
the analysis, women with breast cancer were youngest (median age 67.84) and women with 
colorectal cancer oldest (median age 78.05) at diagnosis.  In addition, women with breast 
cancer were least deprived (median TDS -0.50) and women with lung cancer most deprived 
(median TDS 1.28) at diagnosis.  Whilst exclusion of the youngest 25% at diagnosis led to an 
overall increase in the affluence of the cohorts with lung cancer, the opposite was seen in the 
other groups. 
[Table 1 about here] 
The results of simple linear regression analysis of the ability of TDS at diagnosis to predict 
age at diagnosis are shown in Table 2.  The 95% confidence intervals of the beta coefficients 
of TDS at diagnosis excluded unity in all cases.  The negative beta coefficients seen in 
relation to prostate (beta coefficient -0.073), colorectal (women: -0.042; men: -0.063) and 
lung cancer (women: -0.214; men: -0.161) suggest that individuals living in more deprived 
areas tended to have these cancers diagnosed earlier in life than those living in more affluent 
areas.  These coefficients equate to a variation in age at diagnosis of cancer of between 0.21 
(colorectal cancer, women) and 1.07 years (lung cancer, women) across the inter-quartile 
range of TDS.   
Amongst women with breast cancer, the beta coefficient of TDS at diagnosis was positive 
(0.149) suggesting that women living in more deprived areas tended to have breast cancer 
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diagnosed later in life than those living in more affluent areas.  This equates to a variation of 
0.72 years in age at diagnosis across the inter-quartile range of TDS. 
[Table 2 about here] 
The 1998-2000 cohort 
There were 25 314 cases of colorectal and breast cancer registered with NYCRIS between 1st 
January 1998 and 31st December 2000.  Of these, 11 445 (45.2%) were excluded from the 
analysis – almost half of these exclusions were made on the grounds of missing stage or grade 
data.  There was evidence that those excluded from the analysis on the grounds of missing 
stage or grade data were from more deprived neighbourhoods than those included (p<0.0001) 
and were older (p<0.0001).  Table 3 shows the distribution of age and TDS at incidence in the 
1998-2000 cohort before and after exclusion of the youngest 25% of individuals at diagnosis.  
As before, women with breast cancer tended to be youngest (median age 63.30) and women 
with colorectal cancer tended to oldest (median age 76.11) at diagnosis.  Individuals included 
in the 1998-2000 cohort tended to be more affluent and slightly younger at cancer incidence 
than those in comparable groups in the main 1986-1995 cohort. 
[Table 3 about here] 
Table 4 shows the results of linear regression analyses of the ability of TDS at diagnosis to 
predict age at diagnosis both before and after adjustment for stage and grade at diagnosis.  
There was less evidence of statistically significant relationships between TDS and age at 
diagnosis in this cohort compared to the 1986-1995 cohort.  However, adjustment for stage 
and grade at diagnosis had little effect on the magnitude of the beta coefficients in all three 
site and gender specific groups in the 1998-2000 cohort. 
[Table 4 about here] 
Discussion 
This is the first study that has assessed the socio-economic distribution of either age at 
diagnosis of cancer or other possible markers of biological ageing.  Using data from more 
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than 100 000 individuals, we found evidence of a small, negative, effect of TDS on age at 
diagnosis of prostate, lung and colorectal cancers.  Individuals living in more materially 
deprived areas tended to have these cancers diagnosed earlier in life with a difference of 
between 0.21 and 1.07 years in age at diagnosis of cancer across the inter-quartile range of 
TDS.  The opposite relationship was found amongst women with breast cancer with women 
living in more deprived areas tending to have breast cancer diagnosed later in life than those 
living in less deprived areas.  In a second analysis, adjusting for stage and grade of cancer at 
incidence had very little effect on the magnitude of the effect of TDS on age at diagnosis for 
breast and colorectal cancers. 
Although routinely collected data, such as used here, is not always of high quality, there is 
reason to believe that the UK cancer registries, and NYCRIS in particular, collect data of a 
consistently high standard.[21]  For example, in 1994 NYCRIS collected contemporaneous 
data from more than 93% of individuals who died with cancer in the region – compared with 
a UK average of only 88%.[24]  In addition, only 497 (0.3% of the total number of 
registrations) individuals were excluded from the main cohort in the present study due to 
missing data.  We are, therefore, confident that our analysis, at least of the main 1986-1995 
cohort, used high quality data with good ascertainment and completeness.  In contrast, 
substantial exclusions were made from the 1998-2000 cohort due to missing data on stage or 
grade of cancer.  We are, therefore, less confident of the quality of this data and cannot be 
sure that adjusting for stage and grade of cancer in this cohort provided us with a clear picture 
of actual effect of this procedure in a more complete cohort. 
It is not necessarily desirable or appropriate to apply area based measures of SEP, such as 
TDS, to individuals as done here.  The process involves both the assumption that small areas 
are relatively socio-economically homogeneous and that there may be significant temporal 
extrapolation of data.[2526]  However, the limitations of the data collected by NYCRIS 
meant that an area based measure of SEP were all that was available to us.  A wide variety of 
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previous work has applied TDS to individuals[27-31] and we made the pragmatic decision to 
use TDS as an individual measure of SEP in order to make use of this large and rich dataset. 
We used age at diagnosis of cancer as a proxy for age at development of cancer.  Any socio-
economic variations in the length of time between cancer development and diagnosis 
therefore have the potential to confound the relationships seen.  However, the research 
evidence concerning socio-economic variations in diagnostic delay is far from consistent[32-
35] and adjustment for stage and grade at incidence (two key markers of cancer progression 
and, therefore, diagnostic delay) in the present study had very little effect on the magnitude of 
the effect of TDS on age at diagnosis, suggesting that variations in timeliness of diagnosis did 
not explain the results seen.  Given the quality of this data we cannot., however be confident 
of this conclusion.  However, recent research has reported an inverse association between 
deprivation and proximity to health services[36] suggesting that more deprived individuals 
are actually more likely to live in close proximity to treatment centres than more affluent ones.  
It is hard to define, even theoretically, exactly when a cancer occurs.  Using the date at which 
a cancer is clinically detectable is one possible method but this would require a large 
prospective screening study with a short time span between screens.  Our analyses have 
provided preliminary data in this area without recourse to such a lengthy and resource 
intensive study. 
In addition to using date of diagnosis as a proxy for date of development of cancer, we also 
used it as a proxy for biological ageing.  Although we believe that age at diagnosis of cancer 
is a useful comparative clinical marker of the rate of biological ageing, the pathways between 
biological ageing and diagnosis of cancer are long and complex and the cellular damage 
responsible for cancer is not necessarily the same cellular damage responsible for biological 
ageing.  The results presented here can only begin to untangle the relationship, if any, 
between SEP and biological ageing. 
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Because our hypothesis focuses on environmental risk and protective factors, we felt that it 
was important to exclude individuals with cancers that had a substantial inherited component.  
This was done, somewhat arbitrarily, by excluding the youngest 25% of each gender and site 
specific group on the basis that inherited cancers are likely to occur earlier in life than 
sporadic ones, with inevitable knock on effects on the age and TDS distributions of the 
cohorts used in the analyses.[22]  However, the division between cancers with a large 
inherited component and those that are primarily sporadic is not clear cut and not all of the 
25% of cancers occurring at the youngest ages will necessarily have a predominant inherited 
component, nor will all cancers with a strong inherited component necessarily occur within 
this age group.   
Further, despite the statistical significance of the influence of TDS on age at diagnosis found, 
the effect sizes seen were small with a standard deviation change in TDS at diagnosis 
resulting in less than a year change in age at diagnosis of cancer.  The inaccuracies in our 
measure of biological ageing and the effects of unknown confounders may contribute to the 
minimal effect size seen and further research investigating socio-economic variations of more 
accurate markers of biological ageing is warranted. 
We have identified two possible explanations for the main finding that age at diagnosis of 
prostate, colorectal and lung cancer decreases with increasing deprivation of the area of 
residence.  Firstly, it is possible that the cancers that individuals across the socio-economic 
spectrum develop are biologically different in some way that leads to variations in age of 
onset.  It has been highlighted that not all cancers, even of the same tissue, involve the same 
disease process.[37]  Given the different environmental risks and hazards, and therefore 
carcinogens, that individuals across the socio-economic spectrum are exposed to, it is possible 
that, despite being classified under the same ICD heading in the NYCRIS database, not all 
cancers that we have analysed are comparable.  Although such biological variations have been 
documented according to age,[38-40] we are not aware of any evidence that the biological 
nature of individual cancer types varies by SEP.  An alternative explanation of our findings is 
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that the rate of accumulation of damage at the cellular level, and thus biological ageing, is 
socio-economically patterned due to socio-economic patterning of exposure to carcinogenic 
risk factors (Figure 1).   
Neither of the preceding explanations can be applied to the results seen amongst women with 
breast cancer.  The one key difference in the diagnosis of breast cancer in British women, 
compared to the other cancers studied, is the presence of the UK national breast cancer 
screening programme.  This programme invites all women aged between 50 and 64 for 
triennial mammography.  Although highly successful in detecting early breast cancer and 
reducing morbidity and mortality,[41] uptake of breast screening in the UK is known to be 
socio-economically patterned with more affluent women tending to attend more regularly 
than less affluent women.[4243]  It is, therefore, possible that the tendency we found for more 
affluent women to have breast cancer diagnosed at younger ages is due to their more regular 
attendance for breast cancer screening and resultant more timely diagnosis of breast cancer.  
As we did not have information of who did and did not attend for screening, we were unable 
to explore this possibility further.  However, the plausibility of this explanation further calls 
into question the accuracy of our adjustment for stage and grade of cancer at diagnosis in the 
1998-2000 cohort. 
Conclusions 
By providing evidence that the age at diagnosis of some common cancers is socio-
economically patterned, this study provides preliminary evidence that the rate of biological 
ageing may also be socio-economically patterned.  Furthermore, we found little evidence that 
socio-economic variations in diagnostic delay – as measured by stage or grade of cancer at 
diagnosis – were confounding the relationships seen.  To further investigate the relationship 
between SEP and biological ageing, studies using longitudinal measures of individual socio-
economic circumstances across the lifecourse and measures of the actual process of biological 
ageing at the cellular level, rather than the clinical outcomes of it, will be required.   
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Key points 
• Rate of biological ageing may mediate the relationship between socio-economic position 
and health and age at diagnosis of cancer may be a comparative marker of biological 
ageing with earlier age at diagnosis being indicative of faster biological ageing. 
• More deprived individuals tended to develop colorectal, lung and prostate cancer earlier 
in life than more affluent individuals.  The opposite trend was seen in relation to breast 
cancer. 
Policy implications 
• If the rate of biological ageing is confirmed as mediating the relationship between socio-
economic position and health, targeting interventions which reduce the rate of biological 
ageing at deprived populations may help reduce socio-economic variations in health. 
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Table 1 – Distribution of age and Townsend Deprivation Score at diagnosis of cancer (1986-1995 cohort) 
 Before exclusion of youngest 25% at diagnosis After exclusion of youngest 25% at diagnosis 
  Age TDS‡  Age TDS‡ 
 N Median IQR† Median IQR† N Median IQR† Median IQR† 
Prostate cancer 17 107 74.80 68.89 to 80.47 -0.51 -2.66 to 2.27 12 828 77.63 73.48 to 82.11 -0.35 -2.58 to 2.40 
Breast cancer, women 34 265 62.63 51.44 to 73.67 -0.57 -2.73 to 2.23 25 697 67.84 60.09 to 76.92 -0.50 -2.65 to 2.19 
Colorectal cancer, women 16 872 74.29 65.65 to 81.62 -0.11 -2.43 to 2.68 12 656 78.05 72.41 to 83.53 0.03 -2.27 to 2.71 
Colorectal cancer, men 18 053 70.30 62.78 to 77.28 -0.02 -2.46 to 2.81 13 538 73.67 68.51 to 79.29 0.06 -2.36 to 2.81 
Lung cancer, women 18 116 69.78 63.23 to 77.28 1.36 -1.38 to 3.72 14 165 72.46 67.65 to 78.14 1.28 -1.38 to 3.64 
Lung cancer, men 35 273 70.03 63.75 to 76.31 1.23 -1.50 to 3.66 26 442 72.98 68.58 to 78.24 1.09 -1.55 to 3.54 
†inter-quartile range;  ‡Townsend Deprivation Score 
 
Table 2 – Linear regression models of the ability of Townsend Deprivation Score to predict age at diagnosis of cancer (1986-1995 cohort) 
 beta coefficient (95% CI*) t
 
(p-value) adjusted r2 Change in age/TDS IQR+ 
Prostate cancer -0.073 (-0.106 to -0.041) -4.446 (<0.0001) 0.001 -0.36 years 
Breast cancer 0.149 (0.109 to 0.193) 7.018 (<0.0001) 0.002 0.72 years 
Colorectal cancer, women -0.042 (-0.081 to -0.004) -2.070 (0.039) <0.001 -0.21 years 
Colorectal cancer, men -0.063 (-0.100 to -0.027) -3.367 (0.001) 0.001 -0.33 years 
Lung cancer, women -0.214 (-0.252 to -0.177) -11.350 (<0.0001) 0.009 -1.07 years 
Lung cancer, men -0.161 (-0.185 to -0.136) -12.886 (<0.0001) 0.006 -0.82 years 
*95% confidence intervals (bias corrected) of beta derived from bootstrapping with 1000 repetitions; +change in age at diagnosis of cancer across the 
interquartile range in Townsend Deprivation Score from lower (most affluent) quartile to upper (most deprived quartile) 
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Table 3 – Distribution of age and Townsend Deprivation Score at diagnosis of cancer (1998-2000 cohort) 
 Before exclusion of youngest 25% at diagnosis After exclusion of youngest 25% at diagnosis 
  Age TDS‡  Age TDS‡ 
 N Median IQR† Median IQR† N Median IQR† Median IQR† 
Breast cancer, women 9920 58.50 50.18 to 69.21 -1.04 -2.99 to 1.79 7441 63.30 55.99 to 72.63 -1.04 -3.00 to 1.82 
Colorectal cancer, women 3707 72.67 64.54 to 79.45 -0.54 -2.74 to 2.44 2781 76.11 70.86 to 81.46 -0.39 -2.65 to 2.51 
Colorectal cancer, men 4861 70.38 62.68 to 76.62 -0.72 -2.78 to 2.21 3647 73.71 68.72 to 78.30 -0.64 -2.74 to 2.26 
†inter-quartile range;  ‡Townsend Deprivation Score;   
 
 
Table 4 – Linear regression models of the ability of Townsend Deprivation Score to predict age at diagnosis of cancer before and after adjustment 
for, stage and grade at diagnosis (1998-2000 cohort) 
 Unadjusted Adjusted for stage and grade at diagnosis of cancer 
 
beta (95% CI*) t
 
(p-value) adjusted r2 
Change in 
age/TDS IQR+ beta (95% CI*) 
t
 
(p-value) adjusted r2 Change in 
age/TDS IQR+ 
Breast cancer 0.227 (0.159 to 0.306) 6.069 (<0.0001) 0.005 1.09 years 0.205 (0.127 to 0.285) 5.533 (<0.0001) 0.021 0.99 years 
Colorectal cancer, women 0.009 (-0.074 to 0.096) 0.151 (0.880) <0.0001 0.05 years 0.012 (-0.073 to 0.088) 0.226 (0.821) <0.0001 0.06 years 
Colorectal cancer, men -0.056 (-0.119 to 0.012) -1.617 (0.106) <0.0001 -0.28 years -0.055 (-0.128 to 0.011) -1.572 (0.116) <0.0001 0.28 years 
*95% confidence intervals (bias corrected) of beta derived from bootstrapping with 1000 repetitions; +change in age at diagnosis of cancer across the 
interquartile range in Townsend Deprivation Score from lower (most affluent) quartile to upper (most deprived quartile) 
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Figure 1 – The hypothesised pathway linking socio-economic position, environmental risk and protective factors, biological ageing and health status 
 
Socio-economic 
position 
Exposure to 
environmental risk and 
protective factors 
Rate of biological ageing 
(rate of accumulation of 
cellular damage) 
Health 
status 
Other fundamental pathways 
linking SEP and health 
Other determinants of biological 
ageing (e.g. genetics) 
Other determinants 
of health 
PRE-PUBLICATION MANUSCRIPT – NOT TO BE COPIED OR QUOTED 
WITHOUT PERMISSION 
  17 
References 
1. Whitehead M. Inequalities in health:  The health divide. 3rd ed. Suffolk, Penguin 
Books, 1992. 
2. Acheson D. Report of the independent enquiry into inequalities in health. London, 
Stationary Office, 1998. 
3. Townsend P, Davidson N, editors. Inequalities in health:  The Black Report. Suffolk, 
Penguin Books, 1982. 
4. Townsend P, Phillimore P, Beattie A. Health and deprivation:  inequality and the 
North. Bristol, Croom Helm, 1988. 
5. Charlton B, White M. Living on the margin:  A salutogenic model for socio-
economic differentials in health. Public Health 1995;109:235-243. 
6. Fuhrer R, Shipley M, Chastang J, et al. Socioeconomic position, health and possible 
explanations: a tale of two cohorts. American Journal of Public Health 2002;92(8):1290-1294. 
7. Adams J, White M. Biological ageing: A fundamental, biological link between socio-
economic status and health? European Journal of Public Health 2003;In press. 
8. Germov J, editor. Second opinion: an introduction to health sociology. Singapore, 
Oxford University Press, 1998. 
9. Fries J, Crapo L. Vitality and aging: implications of the rectangular shaped curve. 
USA, WH Freeman and Company, 1981. 
10. Kirkwood T, Austad S. Why do we age? Nature 2000;408:233-8. 
11. Kirkwood T, Kowald A. Network theory of ageing. Experimental Gerontology 
1997;32(4/5):395-9. 
12. Wick G, Jansen-Durr P, Berger P, et al. Diseases of aging. Vaccine 2000;18:1567-
1583. 
13. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. 
Nature 2000;408(6809):255-62. 
14. Cournil A, Kirkwood T. If you would live long, choose your parents well. Trends in 
Genetics 2001;17(5):233-5. 
15. MacNee W. Oxidants/antioxidants and COPD. Chest 2000;117(5 (suppl 1)):303S-
317S. 
16. Taylor A, Jaques P, Epstein E. Relations among aging, antioxidant status, and 
cataract. Journal of Clinical Nutrition 1995;62(Suppl):1439s-1447s. 
17. Young R. Age-related cataract. New York, Oxford University Press, 1991. 
18. Drever F, Whitehead M, editors. Health inequalities decennial supplement. London, 
The Stationary Office, 1997. 
PRE-PUBLICATION MANUSCRIPT – NOT TO BE COPIED OR QUOTED 
WITHOUT PERMISSION 
  18 
19. Crimmins E, Saito Y. Trends in healthy life expectancy in the United States, 1970-
1990:   gender, racial, and educational differences. Social Science and Medicine 
2001;52:1629-1641. 
20. Bishop J, Weinberg R, editors. Molecular oncology. USA, Scientific American Inc, 
1996. 
21. Hugget C. Nationwide audit of the quality and comparability of data held by regional 
cancer registries. Bristol: University of Bristol; 1995. 
22. Lindblom A, Nordenskjold M. The biology of inherited cancer. Seminars in Cancer 
Biology 2000;10(4 SU  -):251-254. 
23. Kirkwood B, Sterne J. Essential medical statistics. 2nd ed. Bodmin, Blackwell 
Science, 2003. 
24. Quinn M, Babb P, Brock A, et al. Cancer trends in England and Wales 1950-1999. 
London, The Stationary Office, 2001. 
25. Krieger N, Williams D, Moss N. Measuring social class in US public health research: 
concepts, methodologies and guidelines. Annual review of Public Health 1997;18:341-78. 
26. Carr-Hill R, Chalmers-Dixon P. A review of methods for monitoring and measuring 
social inequality, deprivation and health inequality. York: University of York; 2002. 
27. Taylor A, Cheng K. Social deprivation and breast cancer. Journal of Public Health 
Medicine 2002;25(3):228-33. 
28. McNally R, Alston R, Cairns D, et al. Geographical and ecological analyses of 
childhood acute leukaemias and lymphomas in north-west England. British Journal of 
Haematology 2003;123(1):60-65. 
29. Bundred P, Manning D, Brewster B, et al. Social trends in singleton births and birth 
weight in Wirral residents, 1990-2001. Archives of Disease in Childhood: fetal and perinatal 
2003;88(5):F421-424. 
30. Feltbower R, McKinney P, Campbell F, et al. Type 2 and other forms of diabetes in 
0-30 year olds: a hospital based study in Leeds, UK. Archives of Disease in Childhood 
2003;88(8):676-679. 
31. Aggarwal V, Macfarlane T, Macfarlane G. Why is pain more common amongst 
people living in areas of low socio-economic status? A population-based cross-sectional study. 
British Dental Journal 2003;194(7):383-387. 
32. Macleod U, Ross S, Gillis C, et al. Socio-economic deprivation and stage of disease 
at presentation in women with breast cancer. Annals of Oncology 2000;11:105-107. 
33. Thomson C, Hole D, Twelves C, et al. Prognostic factors in women with breast 
cancer: distribution by socioeconomic status and effect on difference in survival. Journal of  
Epidemiology & Community Health 2001;55:308-315. 
34. Brewster D, Thomson C, Hole D, et al. Relation between socioeconomic status and 
tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four 
national, population based studies. British Medical Journal 2001;322:830-831. 
PRE-PUBLICATION MANUSCRIPT – NOT TO BE COPIED OR QUOTED 
WITHOUT PERMISSION 
  19 
35. Carnon A, Ssemwogerere A, Lamont D, et al. Relation between socioeconomic 
deprivation and pathological prognostic factors in women with breast cancer. British Medical 
Journal 1994;309:1054-1057. 
36. Jordan H, Roderick P, Martin D. The index of multiple deprivation 2000 and 
accessibility effects on health. Journal of  Epidemiology & Community Health 2004;58:250-
257. 
37. Macieira-Coelho A. Neoplastic disease through the human life span. Biogerontology 
2001;2:179-192. 
38. Awadh-Behbehani M, Al-Humood K, Ayed A, et al. Comparison between young and 
old patients with bronchogenic carcinoma. Acta Oncologica 2000;39(8):995-999. 
39. Mettlin C, Murphy G, Cunningham M, et al. The national cancer data base report on 
race, age, and region variations in prostate cancer treatment. Cancer 1997;80:1261-1266. 
40. Erdreich L, Asal N, Hoge A. Morphologic types of breast cancer: age, bilaterality and 
family history. Southern Medical Journal 1980;73(1):28-32. 
41. Blanks R, Moss S, McGahan C, et al. Effect of NHS breast screening programme on 
mortality from breast cancer in England and Wales, 1990-8: comparison of observed with 
predicted mortality. British Medical Journal 2000;321:665-669. 
42. Sutton S, Bickler G, Sancho-Aldridge J, et al. Prospective study of predictors of 
attendance for breast screening in inner London. Journal of  Epidemiology & Community 
Health 1994;48:65-73. 
43. Garvican L, Littlejohns P. Comparison of prognostic and socio-economic factors in 
screen-detected and symptomatic cases of breast cancer. Public Health 1998;112:15-20. 
 
